Histological evaluation at different times after augmentation of extraction sites grafted with a magnesium-enriched hydroxyapatite: double-blinded randomized controlled trial

Clin Oral Implants Res. 2013 Apr;24(4):398-406. doi: 10.1111/clr.12035. Epub 2012 Sep 24.

Abstract

Objectives: To histologically analyze the early angiogenesis-osteogenesis interplay in post-extraction sockets augmented with magnesium-enriched hydroxyapatite (Mg-enriched HA).

Material and methods: Ten post-extraction sites underwent post-extraction ridge preservation procedure. According to randomization, sites were divided into two balanced groups and bone specimens were collected 2 or 4 months after surgery. Sections were stained with hematoxylin/eosin, Masson-Goldner trichrome, and tartrate-resistant acid phosphatase (TRAP), respectively. Furthermore, indirect immunohistochemistry was performed using alkaline phosphatase, CD34 and caveolin-1 antibodies. Mean values and standard deviations were calculated for each outcome variable. Data were then compared using one-way ANOVA test. P < 0.05 was considered statistically significant.

Results: Histomorphometric analysis presented 15.0% (±3.5) regenerated bone after 2 months of healing. After 4 months, regenerated bone increased 5.1-fold up to 77.4% (± 8.6) (P < 0.001). On the contrary, vessels and capillary reduced from 645 (±33) to 255 (± 94) (caveolin-1 expression, P = 0.008). These findings were confirmed by CD34 expression (301 ± 95 and 88 (±24), respectively, at 2 and 4 months (P = 0.046).

Conclusions: Within the limits of the present randomized controlled study, it can be concluded that Mg-enriched HA is a suitable material for socket preservation and ensures early angiogenesis and early osteogenesis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Acid Phosphatase / metabolism
  • Alkaline Phosphatase / metabolism
  • Alveolar Ridge Augmentation / methods*
  • Antibiotic Prophylaxis
  • Antigens, CD34 / metabolism
  • Biopsy
  • Bone Substitutes / pharmacology*
  • Caveolin 1 / metabolism
  • Double-Blind Method
  • Durapatite / pharmacology*
  • Female
  • Humans
  • Immunohistochemistry
  • Isoenzymes / metabolism
  • Magnesium / pharmacology*
  • Male
  • Middle Aged
  • Neovascularization, Physiologic / drug effects*
  • Osteogenesis / drug effects*
  • Staining and Labeling
  • Tartrate-Resistant Acid Phosphatase
  • Tooth Extraction
  • Tooth Socket / surgery*

Substances

  • Antigens, CD34
  • Bone Substitutes
  • Caveolin 1
  • Isoenzymes
  • Durapatite
  • Alkaline Phosphatase
  • Acid Phosphatase
  • Tartrate-Resistant Acid Phosphatase
  • Magnesium